The AERI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AERI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The AERI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View AERI Detailed Price Forecast - CNN Money||View AERI Detailed Summary - Google Finance|
|View AERI Detailed Summary - Yahoo! Finance||View AERI Stock Research & Analysis - Zacks.com|
|View AERI Trends & Analysis - Trade-Ideas||View AERI Major Holders - Barrons|
|View AERI Call Transcripts - NASDAQ||View AERI Breaking News & Analysis - Seeking Alpha|
|View AERI Annual Report - CompanySpotlight.com||View AERI OTC Short Report - OTCShortReport.com|
|View AERI Fundamentals - TradeKing||View AERI SEC Filings - Bar Chart|
|View Historical Prices for AERI - The WSJ||View Performance/Total Return for AERI - Morningstar|
|View the Analyst Estimates for AERI - MarketWatch||View the Earnings History for AERI - CNBC|
|View the AERI Earnings - StockMarketWatch||View AERI Buy or Sell Recommendations - MacroAxis|
|View the AERI Bullish Patterns - American Bulls||View AERI Short Pain Metrics - ShortPainBot.com|
|View AERI Stock Mentions - StockTwits||View AERI Stock Mentions - PennyStockTweets|
|View AERI Stock Mentions - Twitter||View AERI Investment Forum News - Investor Hub|
|View AERI Stock Mentions - Yahoo! Message Board||View AERI Stock Mentions - Seeking Alpha|
|View Insider Transactions for AERI - SECform4.com||View Insider Transactions for AERI - Insider Cow|
|View AERI Major Holdings Summary - CNBC||View Insider Disclosure for AERI - OTC Markets|
|View Insider Transactions for AERI - Yahoo! Finance||View Institutional Holdings for AERI - NASDAQ|
|View AERI Stock Insight & Charts - FinViz.com||View AERI Investment Charts - StockCharts.com|
|View AERI Stock Overview & Charts - BarChart||View AERI User Generated Charts - Trading View|
Aerie Pharmaceuticals Announces Appointment of Randall Brown as Director, Payer Marketing
Posted on Monday July 16, 2018
Aerie Pharmaceuticals, Inc. (AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma and other diseases of the eye, today announced the appointment of Randall Brown as Director, Payer Marketing, reporting to Deanne Melloy, Aerie’s Vice President of Marketing. Mr. Brown will support the ongoing development and execution of strategies, programs and communication activities for the payer markets. Mr. Brown previously held related positions at Avanir Pharmaceuticals and AstraZeneca.
See what the IHS Markit Score report has to say about Aerie Pharmaceuticals Inc.
Posted on Thursday July 12, 2018
Short interest is moderately high for AERI with between 10 and 15% of shares outstanding currently on loan. The net inflows of $1.94 billion over the last one-month into ETFs that hold AERI are not among the highest of the last year and have been slowing.
Aerie Pharmaceuticals Has Broken Out on the Upside
Posted on Wednesday June 27, 2018
In this daily bar chart of AERI, below, we can see a decline from December to early May. Despite this decline from $64 to $48 we can see that the daily On-Balance-Volume (OBV) held steady suggesting that traders and investors in AERI did not become aggressive sellers. At the end of May the direction of the OBV line turns up sharply to make a new high.
Aerie Pharmaceuticals Inc’s (NASDAQ:AERI) Shift From Loss To Profit
Posted on Tuesday June 26, 2018
Aerie Pharmaceuticals Inc’s (NASDAQ:AERI): Aerie Pharmaceuticals, Inc., an ophthalmic pharmaceutical company, focuses on the discovery, development, and commercialization of first-in-class therapies for the treatment of glaucoma and other eye diseases.Read More...